Home > Aplastic and Other Anemias > Efficacy > Diamond-Blackfan Anemia

EXJADE Decreases Serum Ferritin Levels in Patients With Diamond-Blackfan Anemia

In 2007, a 1-year prospective phase II study showed that EXJADE reduced levels of serum ferritin in patients with Diamond-Blackfan anemia and other anemias at the 20 and 30 mg/kg/day doses.1

EXJADE Reduces Serum Ferritin Levels in Patients
With Diamond-Blackfan and Other Rare Anemias1
Reduction From Baseline in Serum Ferritin Levels in Patients with Diamond-Blackfan and Other Rare Anemias Chart

In addition, a 1-year multicenter study reported in 2005 that EXJADE decreased serum ferritin levels in Diamond-Blackfan anemia patients (N=30) with iron toxicity.2

EXJADE has shown efficacy in reducing liver iron concentration levels in Diamond-Blackfan anemia patients

In 2007, a 1-year study in patients across a range of anemias (N=184) showed that EXJADE reduced liver iron concentration in patients with Diamond-Blackfan anemia.1

EXJADE Reduces Liver Iron Concentration in Patients
With Diamond-Blackfan Anemias (including aplastic anemia)2,3
EXJADE: LIC in Patients with Diamond-Blackfan anemias

Learn more About
EXJADE dosing.

SAFETY PROFILE
ACROSS ANEMIAS

Learn more